Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Hicks

Showing results (251-260 of 471) with videos related to

Pageof 48
Sort By:
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 16, 2014
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedsideJeremy Lewin, Carleen Cullinane, Tim Akhurst, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomyKenneth B Roberts, Michael P Mac Manus, Rodney J Hicks, et al.
The Medical Journal of Australia|February 22, 2005
Clinical experience with the first combined positron emission tomography/computed tomography scanner in AustraliaW F Eddie Lau, David S Binns, Robert E Ware, et al.
BMC Neurology|June 26, 2007
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control studyRoss P Carne, Terence J O'Brien, Christine J Kilpatrick, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033Donna S Dorow, Carleen Cullinane, Nelly Conus, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse SurvivalSarah Everitt, David Ball, Rodney J Hicks, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneityChian A Chang, David A Pattison, Richard W Tothill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experienceShankar Siva, Keelan Byrne, Matthew Seel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancerMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.
Pageof 48

Showing results (251-260 of 471) with videos related to

Sort By:
Pageof 48
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 16, 2014
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedsideJeremy Lewin, Carleen Cullinane, Tim Akhurst, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomyKenneth B Roberts, Michael P Mac Manus, Rodney J Hicks, et al.
The Medical Journal of Australia|February 22, 2005
Clinical experience with the first combined positron emission tomography/computed tomography scanner in AustraliaW F Eddie Lau, David S Binns, Robert E Ware, et al.
BMC Neurology|June 26, 2007
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control studyRoss P Carne, Terence J O'Brien, Christine J Kilpatrick, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033Donna S Dorow, Carleen Cullinane, Nelly Conus, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse SurvivalSarah Everitt, David Ball, Rodney J Hicks, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneityChian A Chang, David A Pattison, Richard W Tothill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experienceShankar Siva, Keelan Byrne, Matthew Seel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancerMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.
Pageof 48